Patents by Inventor Kristin CERIONE

Kristin CERIONE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210317115
    Abstract: The present invention relates generally to glutaminase inhibitors of Formula I, Formula II, or Formula III, as well as pharmaceutical compounds containing them and methods of their use.
    Type: Application
    Filed: November 17, 2020
    Publication date: October 14, 2021
    Inventors: Richard CERIONE, Kristin CERIONE, Clint STALNECKER, Scott ULRICH
  • Patent number: 10889585
    Abstract: The present invention relates generally to glutaminase inhibitors of Formula I, Formula II, or Formula III, as well as pharmaceutical compounds containing them and methods of their use.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: January 12, 2021
    Assignees: CORNELL UNIVERSITY, ITHACA COLLEGE
    Inventors: Richard Cerione, Kristin Cerione, Clint Stalnecker, Scott Ulrich
  • Publication number: 20200216448
    Abstract: The present invention relates generally to glutaminase inhibitors of Formula I, Formula II, or Formula III, as well as pharmaceutical compounds containing them and methods of their use.
    Type: Application
    Filed: January 6, 2020
    Publication date: July 9, 2020
    Inventors: Richard CERIONE, Kristin CERIONE, Clint STALNECKER, Scott ULRICH
  • Patent number: 10526322
    Abstract: The present invention relates generally to glutaminase inhibitors of Formula I, Formula II, or Formula III, as well as pharmaceutical compounds containing them and methods of their use.
    Type: Grant
    Filed: December 5, 2015
    Date of Patent: January 7, 2020
    Assignees: Cornell University, Ithaca College
    Inventors: Richard Cerione, Kristin Cerione, Clint Stalnecker, Scott Ulrich
  • Publication number: 20170362221
    Abstract: The present invention relates generally to glutaminase inhibitors of Formula I, Formula II, or Formula III, as well as pharmaceutical compounds containing them and methods of their use.
    Type: Application
    Filed: December 5, 2015
    Publication date: December 21, 2017
    Inventors: Richard CERIONE, Kristin CERIONE, Clint STALNECKER, Scott ULRICH